User profiles for Kevin Slawin
Kevin M. Slawin MDFounder and Managing Director, Rapha Capital Management Verified email at raphacap.com Cited by 21052 |
[HTML][HTML] The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia
…, NS Schenkman, KM Slawin… - … England Journal of …, 2003 - Mass Medical Soc
Background Benign prostatic hyperplasia is commonly treated with alpha-adrenergic–receptor
antagonists (alpha-blockers) or 5α-reductase inhibitors. The long-term effect of these …
antagonists (alpha-blockers) or 5α-reductase inhibitors. The long-term effect of these …
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical …
Context.—The percentage of free prostate-specific antigen (PSA) in serum has been shown
to enhance the specificity of PSA testing for prostate cancer detection, but earlier studies …
to enhance the specificity of PSA testing for prostate cancer detection, but earlier studies …
[HTML][HTML] Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
Purpose An increasing serum prostate-specific antigen (PSA) level is the initial sign of
recurrent prostate cancer among patients treated with radical prostatectomy. Salvage radiation …
recurrent prostate cancer among patients treated with radical prostatectomy. Salvage radiation …
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy
ContextSalvage radiotherapy may potentially cure patients with disease recurrence after
radical prostatectomy, but previous evidence has suggested that it is ineffective in patients at …
radical prostatectomy, but previous evidence has suggested that it is ineffective in patients at …
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens
Purpose : The prognostic significance of positive surgical margins (PSM) in radical prostatectomy
(RP) specimens remains unclear. While most studies have concluded that a PSM is an …
(RP) specimens remains unclear. While most studies have concluded that a PSM is an …
A multicenter study of [-2] pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the …
…, JT Wei, GG Klee, CH Bangma, KM Slawin… - The Journal of …, 2011 - auajournals.org
Purpose : Prostate specific antigen and free prostate specific antigen have limited specificity
to detect clinically significant, curable prostate cancer, leading to unnecessary biopsy, and …
to detect clinically significant, curable prostate cancer, leading to unnecessary biopsy, and …
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging
Objectives. Various methods have been proposed to increase the specificity of prostate-specific
antigen (PSA), including age-specific PSA reference ranges, PSA density (PSAD), and …
antigen (PSA), including age-specific PSA reference ranges, PSA density (PSAD), and …
Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors
…, H Huland, H Koh, SF Shariat, KM Slawin… - The Journal of …, 2003 - auajournals.org
Purpose : Men diagnosed with clinically localized prostate cancer have a number of treatment
options available, including watchful waiting, radical prostatectomy and radiation therapy. …
options available, including watchful waiting, radical prostatectomy and radiation therapy. …
Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer
Purpose : We developed a model to predict the side specific probability of extracapsular
extension (ECE) in radical prostatectomy (RP) specimens based on the clinical features of the …
extension (ECE) in radical prostatectomy (RP) specimens based on the clinical features of the …
Survivin expression is associated with features of biologically aggressive prostate carcinoma
…, SM Khoddami, CG Roehrborn, KM Slawin… - Cancer, 2004 - Wiley Online Library
BACKGROUND Survivin counteracts cell death and controls mitotic progression. The
objectives of the current study were to compare the expression patterns of survivin in normal …
objectives of the current study were to compare the expression patterns of survivin in normal …